{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:50:41Z","timestamp":1790823041529,"version":"4.1.0"},"reference-count":308,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Fungal infections impact the lives of at least 12 million people every year, killing over 1.5 million. Wide-spread use of fungicides and prophylactic antifungal therapy have driven resistance in many serious fungal pathogens, and there is an urgent need to expand the current antifungal arsenal. Recent research has focused on improving azoles, our most successful class of antifungals, by looking for synergistic interactions with secondary compounds. Synergists can co-operate with azoles by targeting steps in related pathways, or they may act on mechanisms related to resistance such as active efflux or on totally disparate pathways or processes. A variety of sources of potential synergists have been explored, including pre-existing antimicrobials, pharmaceuticals approved for other uses, bioactive natural compounds and phytochemicals, and novel synthetic compounds. Synergy can successfully widen the antifungal spectrum, decrease inhibitory dosages, reduce toxicity, and prevent the development of resistance. This review highlights the diversity of mechanisms that have been exploited for the purposes of azole synergy and demonstrates that synergy remains a promising approach for meeting the urgent need for novel antifungal strategies.<\/jats:p>","DOI":"10.3390\/ph15040482","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T01:03:01Z","timestamp":1650330181000},"page":"482","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4927-0071","authenticated-orcid":false,"given":"Aidan","family":"Kane","sequence":"first","affiliation":[{"name":"School of Life and Environmental Sciences and Sydney ID, University of Sydney, Camperdown, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4638-0059","authenticated-orcid":false,"given":"Dee A.","family":"Carter","sequence":"additional","affiliation":[{"name":"School of Life and Environmental Sciences and Sydney ID, University of Sydney, Camperdown, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The Changing Epidemiology of Invasive Fungal Infections","volume":"1508","author":"Enoch","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R., and Denning, D. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jinf.2008.12.006","article-title":"Standards of Care for Patients with Invasive Fungal Infections within the United Kingdom: A National Audit","volume":"58","author":"Schelenz","year":"2009","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-Based Analysis of Invasive Fungal Infections, France, 2001-2010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/clinids\/27.5.1138","article-title":"The Epidemiological Features of Invasive Mycotic Infections in the San Francisco Bay Area, 1992-1993: Results of Population-Based Laboratory Active Surveillance","volume":"27","author":"Rees","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/jac\/dkx047","article-title":"Changing Epidemiology of Candidaemia in Australia","volume":"72","author":"Chapman","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","first-page":"E449","article-title":"Burden of Candidemia in the United States, 2017","volume":"71","author":"Tsay","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e01564-17","DOI":"10.1128\/JCM.01564-17","article-title":"Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern","volume":"56","author":"Astvad","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa1714373","article-title":"A Candida auris Outbreak and Its Control in an Intensive Care Setting","volume":"379","author":"Eyre","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/myc.12781","article-title":"An Outbreak Due to Candida auris with Prolonged Colonisation and Candidaemia in a Tertiary Care European Hospital","volume":"61","author":"Moret","year":"2018","journal-title":"Mycoses"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-016-0132-5","article-title":"First Hospital Outbreak of the Globally Emerging Candida auris in a European Hospital","volume":"5","author":"Schelenz","year":"2016","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15585\/mmwr.mm7002e3","article-title":"Candida auris Outbreak in a COVID-19 Specialty Care Unit\u2014Florida, July\u2013August 2020","volume":"70","author":"Prestel","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0966-842X(02)00002-1","article-title":"Candida Biofilms and Their Role in Infection","volume":"11","author":"Douglas","year":"2003","journal-title":"Trends Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11046-008-9100-9","article-title":"Updates on the Epidemiology of Dermatophyte Infections","volume":"166","author":"Seebacher","year":"2008","journal-title":"Mycopathologia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","article-title":"Therapies for the Treatment of Onychomycosis","volume":"31","author":"Gupta","year":"2013","journal-title":"Clin. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/21505594.2019.1596504","article-title":"Exophiala dermatitidis: Key Issues of an Opportunistic Fungal Pathogen","volume":"10","author":"Kirchhoff","year":"2019","journal-title":"Virulence"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/mmy\/myv049","article-title":"Azole Susceptibility of Malassezia pachydermatis and Malassezia furfur and Tentative Epidemiological Cut-off Values","volume":"53","author":"Cafarchia","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/myc.12577","article-title":"The Role of Drug Efflux Pumps in Malassezia pachydermatis and Malassezia furfur Defence against Azoles","volume":"60","author":"Iatta","year":"2017","journal-title":"Mycoses"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal Amphotericin B","volume":"69","author":"Moen","year":"2009","journal-title":"Drugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/jac\/dkw325","article-title":"Global Access to Antifungal Therapy and Its Variable Cost","volume":"71","author":"Kneale","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1093\/clinids\/12.Supplement_3.S318","article-title":"Pharmacokinetics and Tissue Penetration of Fluconazole in Humans","volume":"12","author":"Brammer","year":"1990","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole Resistance in Aspergillus fumigatus: A Side-Effect of Environmental Fungicide Use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1128\/AAC.44.6.1585-1587.2000","article-title":"Does Long-Term Itraconazole Prophylaxis Result in In Vitro Azole Resistance in Mucosal Candida albicans Isolates from Persons with Advanced Human Immunodeficiency Virus Infection?","volume":"44","author":"Goldman","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/tid.12230","article-title":"Development of Echinocandin-Resistant Candida albicans Candidemia Following Brief Prophylactic Exposure to Micafungin Therapy","volume":"16","author":"Ruggero","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e01179-17","DOI":"10.1128\/AAC.01179-17","article-title":"Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans","volume":"62","author":"Bastos","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/QAD.0b013e328352d1d8","article-title":"Decreasing Incidence of Cryptococcal Meningitis in West Africa in the Era of Highly Active Antiretroviral Therapy","volume":"26","author":"Bamba","year":"2012","journal-title":"AIDS"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archinte.165.4.416","article-title":"The Changing Incidence of AIDS Events in Patients Receiving Highly Active Antiretroviral Therapy","volume":"165","author":"Sabin","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.48.5.1773-1777.2004","article-title":"Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis","volume":"48","author":"Bennett","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10096-013-2009-3","article-title":"Candida glabrata: A Review of Its Features and Resistance","volume":"33","author":"Rodrigues","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Chowdhary, A., Sharma, C., and Meis, J.F. (2017). Candida auris: A Rapidly Emerging Cause of Hospital-Acquired Multidrug-Resistant Fungal Infections Globally. PLOS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006290"},{"key":"ref_31","first-page":"1414","article-title":"How to Bolster the Antifungal Pipeline","volume":"347","author":"Denning","year":"2015","journal-title":"Science (1979)"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal Agents: Mechanisms of Action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"Azole Antifungals: 35 Years of Invasive Fungal Infection Management","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e00585-18","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials","volume":"62","author":"Andes","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"624.e1","DOI":"10.1016\/j.ajog.2018.03.001","article-title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Orally Administered VT-1161 in the Treatment of Recurrent Vulvovaginal Candidiasis","volume":"218","author":"Brand","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e01315-18","DOI":"10.1128\/AAC.01315-18","article-title":"In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Monk, B.C., and Keniya, M.V. (2021). Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14\u03b1-Demethylases. J. Fungi, 7.","DOI":"10.3390\/jof7020067"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e00570-17","DOI":"10.1128\/AAC.00570-17","article-title":"Crystal Structure of the New Investigational Drug Candidate VT-1598 in Complex with Aspergillus fumigatus Sterol 14\u03b1-Demethylase Provides Insights into Its Broad-Spectrum Antifungal Activity","volume":"61","author":"Hargrove","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","unstructured":"(2021, March 08). Antifungal Drugs Market Size 2019|Demand|Industry Forecast. Available online: https:\/\/www.reportsanddata.com\/report-detail\/antifungal-drugs-market."},{"key":"ref_41","unstructured":"(2021, March 08). Global Antifungal Drugs Market Report 2020|Orbis Research. Available online: https:\/\/www.orbisresearch.com\/reports\/index\/global-antifungal-drugs-market-report-2020."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/infdis\/jiu017","article-title":"Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype","volume":"209","author":"Zonios","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1128\/AAC.01031-09","article-title":"Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species","volume":"53","author":"Mann","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3389\/fmicb.2019.02788","article-title":"Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris","volume":"10","author":"Chaabane","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.34.2.183","article-title":"Amphotericin B: Current Understanding of Mechanisms of Action","volume":"34","author":"Brajtburg","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current Perspectives on Echinocandin Class Drugs","volume":"6","author":"Perlin","year":"2011","journal-title":"Future Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1369-5274(98)80087-8","article-title":"Antifungals: Mechanism of Action and Resistance, Established and Novel Drugs","volume":"1","author":"Georgopapadakou","year":"1998","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0190-9622(98)70483-9","article-title":"Pharmacokinetics and Pharmacology of Terbinafine and Itraconazole","volume":"38","author":"Leyden","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-1110(88)90020-6","article-title":"Griseofulvin","volume":"195","author":"Larizza","year":"1988","journal-title":"Mutat. Res.\/Rev. Genet. Toxicol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: A Review of Its Pharmacology, Clinical Indications, Pharmacokinetics, Toxicity and Drug Interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","article-title":"An A643T Mutation in the Transcription Factor Upc2p Causes Constitutive ERG11 Upregulation and Increased Fluconazole Resistance in Candida albicans","volume":"54","author":"Heilmann","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.4155\/fmc-2016-0050","article-title":"Targeting Efflux Pumps to Overcome Antifungal Drug Resistance","volume":"8","author":"Holmes","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"Efflux-Mediated Antifungal Drug Resistance","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/EC.00091-07","article-title":"Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae","volume":"6","author":"Lamping","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"ref_55","first-page":"367","article-title":"Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science (1979)"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Selmecki, A.M., Dulmage, K., Cowen, L.E., Anderson, J.B., and Berman, J. (2009). Acquisition of Aneuploidy Provides Increased Fitness during the Evolution of Antifungal Drug Resistance. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000705"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR\/L98H Mutation in the Cyp51A Gene","volume":"55","author":"Lockhart","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Gonzalez-Jimenez, I., Lucio, J., Amich, J., Cuesta, I., Arroyo, R.S., Alcazar-Fuoli, L., and Mellado, E. (2020). A CYP51b Mutation Contributes to Azole Resistance in Aspergillus fumigatus. J. Fungi, 6.","DOI":"10.3390\/jof6040315"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1128\/AAC.00905-16","article-title":"Aspergillus fumigatus Intrinsic Fluconazole Resistance Is Due to the Naturally Occurring T301I Substitution in Cyp51Ap","volume":"60","author":"Leonardelli","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-like Transcription Factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Hagiwara, D., Miura, D., Shimizu, K., Paul, S., Ohba, A., Gonoi, T., Watanabe, A., Kamei, K., Shintani, T., and Moye-Rowley, W.S. (2017). A Novel Zn2-Cys6 Transcription Factor AtrR Plays a Key Role in an Azole Resistance Mechanism of Aspergillus fumigatus by Co-Regulating Cyp51A and Cdr1B Expressions. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006096"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e01134-18","DOI":"10.1128\/AAC.01134-18","article-title":"Crystal Structures of Full-Length Lanosterol 14\u03b1-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery","volume":"62","author":"Keniya","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.01630-08","article-title":"Three-Dimensional Model of Lanosterol 14\u03b1-Demethylase from Cryptococcus neoformans: Active-Site Characterization and Insights into Azole Binding","volume":"53","author":"Sheng","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"149S","DOI":"10.1592\/phco.21.12.149S.34505","article-title":"Rationale for Combination Antifungal Therapy","volume":"21","author":"Lewis","year":"2001","journal-title":"Pharmacotherapy"},{"key":"ref_65","first-page":"530","article-title":"Three-Day Treatment with Butoconazole Nitrate for Vulvovaginal Candidiasis","volume":"64","author":"Droegemueller","year":"1984","journal-title":"Obstet. Gynecol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1439-0450.1997.tb00964.x","article-title":"In Vitro Activity of Climbazole, Clotrimazole and Silver-Sulphadiazine against Isolates of Malassezia pachydermatis","volume":"44","author":"Schmidt","year":"1997","journal-title":"J. Vet. Med. Ser. B"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000238151","article-title":"Vaginal Secretion Levels after 6 Days, 3 Days and 1 Day of Treatment with 100, 200 and 500 Mg Vaginal Tablets of Clotrimazole and Their Therapeutic Efficacy","volume":"28","author":"Mendling","year":"1982","journal-title":"Chemotherapy"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/JCM.41.11.5209-5211.2003","article-title":"In Vitro Activities of the New Antifungal Drug Eberconazole and Three Other Topical Agents against 200 Strains of Dermatophytes","volume":"41","author":"Inza","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_69","first-page":"224","article-title":"Biological and Toxicological Properties of Econazole, a Broad Spectrum Antimycotic","volume":"25","author":"Thienpont","year":"1975","journal-title":"Arzneim.-Forsch.\/Drug Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1439-0507.1995.tb00070.x","article-title":"The Anti-Malassezia furfur Activity In Vitro and in Experimental Dermatitis of Six Imidazole Antifungal Agents: Bifonazole, Clotrimazole, Flutrimazole, Ketoconazole, Miconazole and Sertaconazole","volume":"38","author":"Gerven","year":"1995","journal-title":"Mycoses"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/myc.12054","article-title":"Isoconazole Nitrate: A Unique Broad-Spectrum Antimicrobial Azole Effective in the Treatment of Dermatomycoses, Both as Monotherapy and in Combination with Corticosteroids","volume":"56","author":"Veraldi","year":"2013","journal-title":"Mycoses"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.1987.tb05815.x","article-title":"Treatment of Seborrhoeic Dermatitis with Ketoconazole: II. Response of Seborrhoeic Dermatitis of the Face, Scalp and Trunk to Topical Ketoconazole","volume":"116","author":"Green","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/CE.S49629","article-title":"Luliconazole for the Treatment of Fungal Infections: An Evidence-Based Review","volume":"9","author":"Khanna","year":"2014","journal-title":"Core Evid."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000220875","article-title":"Miconazole, a Broad-Spectrum Antimycotic Agent with Antibacterial Activity","volume":"17","author":"Thienpont","year":"1972","journal-title":"Chemotherapy"},{"key":"ref_75","first-page":"17","article-title":"Oxiconazole, a New Imidazole Derivative. Evaluation of Antifungal Activity In Vitro and In Vivo","volume":"32","author":"Polak","year":"1982","journal-title":"Arzneim.-Forsch.\/Drug Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-006-0679-8","article-title":"Anti-Inflammatory and Anti-Itch Activity of Sertaconazole Nitrate","volume":"298","author":"Liebel","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14787210.3.3.333","article-title":"Sertaconazole: Updated Review of a Topical Antifungal Agent","volume":"3","author":"Giusiano","year":"2005","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003495-198835020-00004","article-title":"Sulconazole: A Review of Its Antimicrobial Activity and Therapeutic Use in Superficial Dermatomycoses","volume":"35","author":"Benfield","year":"1988","journal-title":"Drugs"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0040517513515312","article-title":"The Efficacy of Antifungal Azole and Antiprotozoal Compounds in Protection of Wool from Keratin-Digesting Insect Larvae","volume":"84","author":"Sunderland","year":"2014","journal-title":"Text. Res. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/AAC.15.4.597","article-title":"Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative","volume":"15","author":"Jevons","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-98-1-13","article-title":"Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 Patients. National Institute of Allergy and Infectious Diseases Collaborative Antifungal Study","volume":"98","author":"Dismukes","year":"1983","journal-title":"Ann. Intern. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% Solution in the Treatment of Toenail Onychomycosis: Two Phase III Multicenter, Randomized, Double-Blind Studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000238215","article-title":"Terconazole\u2014A New Broad-Spectrum Antifungal","volume":"29","author":"Zaman","year":"1983","journal-title":"Chemotherapy"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2125.2004.02107.x","article-title":"Pharmacokinetics of Fosfluconazole and Fluconazole Following Multiple Intravenous Administration of Fosfluconazole in Healthy Male Volunteers","volume":"58","author":"Sobue","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"274768","DOI":"10.1155\/2009\/274768","article-title":"Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants","volume":"2009","author":"Takahashi","year":"2009","journal-title":"Int. J. Pediatr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/1346-8138.14607","article-title":"Efficacy and Safety of Fosravuconazole L-Lysine Ethanolate, a Novel Oral Triazole Antifungal Agent, for the Treatment of Onychomycosis: A Multicenter, Double-Blind, Randomized Phase III Study","volume":"45","author":"Watanabe","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0923-1811(93)90072-W","article-title":"Itraconazole\u2014A New Oral Antifungal Agent with a Very Broad Spectrum of Activity in Superficial and Systemic Mycoses","volume":"5","author":"Odds","year":"1993","journal-title":"J. Dermatol. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(05)70297-8","article-title":"Posaconazole: A Broad-Spectrum Triazole Antifungal","volume":"5","author":"Torres","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/13543784.11.3.409","article-title":"Review of the Safety and Efficacy of Voriconazole","volume":"11","author":"Hoffman","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_91","unstructured":"(2021, March 16). BioCentury\u2014Abasol Abafungin Regulatory Update. Available online: https:\/\/www.biocentury.com\/article\/126706\/abasol-abafungin-regulatory-update."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, Antagonism, and What the Chequerboard Puts between Them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1038\/s41598-018-25714-z","article-title":"Synergistic Combination of Two Antimicrobial Agents Closing Each Other\u2019s Mutant Selection Windows to Prevent Antimicrobial Resistance","volume":"8","author":"Xu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","article-title":"Antibiotic Combination Therapy against Resistant Bacterial Infections: Synergy, Rejuvenation and Resistance Reduction","volume":"18","author":"Coates","year":"2020","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Zubko, E.I., and Zubko, M.K. (2013). Co-Operative Inhibitory Effects of Hydrogen Peroxide and Iodine against Bacterial and Yeast Species. BMC Res. Notes, 6.","DOI":"10.1186\/1756-0500-6-272"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/acsinfecdis.0c00721","article-title":"Combining Colistin and Fluconazole Synergistically Increases Fungal Membrane Permeability and Antifungal Cidality","volume":"7","author":"Bibi","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-Positive Patients Starting Antiretroviral Therapy between 1996 and 2013: A Collaborative Analysis of Cohort Studies","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","article-title":"Antimalarial Drug Synergism and Antagonism: Mechanistic and Clinical Significance","volume":"253","author":"Bell","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1093\/infdis\/128.Supplement_3.S433","article-title":"Mechanism of Action of Trimethoprim-Sulfamethoxazole","volume":"128","author":"Hitchings","year":"1973","journal-title":"J. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9343(87)90691-7","article-title":"Toxicity of Amphotericin B plus Flucytosine in 194 Patients with Cryptococcal Meningitis","volume":"83","author":"Stamm","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"451","DOI":"10.14740\/jocmr2992w","article-title":"Combination Antifungal Therapy: A Review of Current Data","volume":"9","author":"Campitelli","year":"2017","journal-title":"J. Clin. Med. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination Antifungal Therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/AAC.45.3.966-968.2001","article-title":"Synergism of Voriconazole and Terbinafine against Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis","volume":"45","author":"Weig","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/CDLI.6.6.921-923.1999","article-title":"Successful Treatment of Fluconazole-Resistant Oropharyngeal Candidiasis by a Combination of Fluconazole and Terbinafine","volume":"6","author":"Ghannoum","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/JCM.40.5.1831-1833.2002","article-title":"In Vitro Activities of Terbinafine in Combination with Fluconazole, Itraconazole, Voriconazole, and Posaconazole against Clinical Isolates of Candida glabrata with Decreased Susceptibility to Azoles","volume":"40","author":"Perea","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1128\/AAC.49.4.1593-1596.2005","article-title":"Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest Methods","volume":"49","author":"Gobernado","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.44.2.470-472.2000","article-title":"In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans","volume":"44","author":"Meletiadis","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1128\/AAC.47.1.106-117.2003","article-title":"In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates","volume":"47","author":"Meletiadis","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/mmy.39.1.91.95","article-title":"Synergistic Interaction of Terbinafine with Triazoles or Amphotericin B against Aspergillus Species","volume":"39","author":"Ryder","year":"2001","journal-title":"Med. Mycol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e0144921","DOI":"10.1128\/AAC.01449-21","article-title":"In Vitro Antifungal Combination of Terbinafine with Itraconazole against Isolates of Trichophyton Species","volume":"66","author":"Bidaud","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/AAC.41.8.1812","article-title":"In Vitro Activities of Terbinafine in Combination with Fluconazole and Itraconazole against Isolates of Candida albicans with Reduced Susceptibility to Azoles","volume":"41","author":"Barchiesi","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.04469-14","article-title":"The Strength of Synergistic Interaction between Posaconazole and Caspofungin Depends on the Underlying Azole Resistance Mechanism of Aspergillus fumigatus","volume":"59","author":"Mavridou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/jac\/dkaa185","article-title":"In Vitro Interaction of Isavuconazole and Anidulafungin against Azole-Susceptible and Azole-Resistant Aspergillus fumigatus Isolates","volume":"75","author":"Buil","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e01056-17","DOI":"10.1128\/AAC.01056-17","article-title":"In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris","volume":"61","author":"Fakhim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.diagmicrobio.2018.03.003","article-title":"In Vitro Combination of Voriconazole with Micafungin against Azole-Resistant Clinical Isolates of Aspergillus fumigatus from Different Geographical Regions","volume":"91","author":"Fakhim","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e02031-20","DOI":"10.1128\/AAC.02031-20","article-title":"Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program","volume":"65","author":"Pfaller","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Caballero, U., Kim, S., Eraso, E., Quind\u00f3s, G., Vozmediano, V., Schmidt, S., and Jauregizar, N. (2021). In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris. Antibiotics, 10.","DOI":"10.3390\/antibiotics10040355"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bjophthalmol-2017-310683","article-title":"In Vitro Synergy of Natamycin and Voriconazole against Clinical Isolates of Fusarium, Candida, Aspergillus and Curvularia spp.","volume":"102","author":"Sradhanjali","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2133.2003.05418.x","article-title":"In Vitro Susceptibility Testing of Ciclopirox, Terbinafine, Ketoconazole and Itraconazole against Dermatophytes and Nondermatophytes, and In Vitro Evaluation of Combination Antifungal Activity","volume":"149","author":"Gupta","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e01393-19","DOI":"10.1128\/AAC.01393-19","article-title":"In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism","volume":"63","author":"Bidaud","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Macedo, D., Leonardelli, F., Dudiuk, C., Vitale, R.G., del Valle, E., Giusiano, G., Gamarra, S., and Garcia-Effron, G. (2019). In Vitro and In Vivo Evaluation of Voriconazole-Containing Antifungal Combinations against Mucorales Using a Galleria mellonella Model of Mucormycosis. J. Fungi, 5.","DOI":"10.3390\/jof5010005"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1439-0507.1993.tb00686.x","article-title":"Combination of Amorolfine with Various Antifungal Drugs in Dermatophytosis","volume":"36","author":"Polak","year":"2009","journal-title":"Mycoses"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1348-0421.12109","article-title":"In Vitro Susceptibility of Dermatomycoses Agents to Six Antifungal Drugs and Evaluation by Fractional Inhibitory Concentration Index of Combined Effects of Amorolfine and Itraconazole in Dermatophytes","volume":"58","author":"Tamura","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.2001.00044.x","article-title":"Amorolfine and Itraconazole Combination for Severe Toenail Onychomycosis; Results of an Open Randomized Trial in Spain","volume":"145","author":"Lecha","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/myc.12632","article-title":"Production of Trichophyton rubrum Microspores in Large Quantities and Its Application to Evaluate Amorolfine\/Azole Compound Interactions In Vitro","volume":"60","author":"Laurent","year":"2017","journal-title":"Mycoses"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/mmy\/myv063","article-title":"In Vitro Antifungal Synergy between Amphiphilic Aminoglycoside K20 and Azoles against Candida Species and Cryptococcus neoformans","volume":"53","author":"Shrestha","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e00256-20","DOI":"10.1128\/mSphere.00256-20","article-title":"Oxadiazole-Containing Macrocyclic Peptides Potentiate Azole Activity against Pathogenic Candida Species","volume":"5","author":"Revie","year":"2020","journal-title":"mSphere"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijantimicag.2018.08.016","article-title":"Synergistic Interactions of Sulfamethoxazole and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris","volume":"52","author":"Eldesouky","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e00701-17","DOI":"10.1128\/AAC.00701-17","article-title":"Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs","volume":"62","author":"Eldesouky","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/1567-1364.12048","article-title":"Synergistic Effect of Doxycycline and Fluconazole against Candida albicans Biofilms and the Impact of Calcium Channel Blockers","volume":"13","author":"Gao","year":"2013","journal-title":"FEMS Yeast Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/mmy\/myy008","article-title":"In Vitro Synergy with Fluconazole plus Doxycycline or Tigecycline against Clinical Candida glabrata Isolates","volume":"57","author":"Hooper","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jgar.2017.11.011","article-title":"In Vivo Activity of Fluconazole\/Tetracycline Combinations in Galleria mellonella with Resistant Candida albicans Infection","volume":"13","author":"Gu","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1099\/jmm.0.000301","article-title":"In Vitro Synergistic Combinations of Pentamidine, Polymyxin B, Tigecycline and Tobramycin with Antifungal Agents against Fusarium spp.","volume":"65","author":"Venturini","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e5263","DOI":"10.7717\/peerj.5263","article-title":"In Vitro Activities of Antifungals Alone and in Combination with Tigecycline against Candida albicans Biofilms","volume":"2018","author":"Hacioglu","year":"2018","journal-title":"PeerJ"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e00290-20","DOI":"10.1128\/AAC.00290-20","article-title":"In Vitro and In Vivo Study on the Synergistic Effect of Minocycline and Azoles against Pathogenic Fungi","volume":"64","author":"Gao","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3389\/fmicb.2021.649026","article-title":"Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species","volume":"12","author":"Tan","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"101227","DOI":"10.1016\/j.mycmed.2021.101227","article-title":"In Vitro Synergistic Effect of Minocycline Combined with Antifungals against Cryptococcus neoformans","volume":"32","author":"Tan","year":"2022","journal-title":"J. Med. Mycol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Yang, F., Sun, Y., and Lu, Q. (2022). The Synergistic Effect of Minocycline and Azole Antifungal Drugs against Scedosporium and Lomentospora Species. BMC Microbiol., 22.","DOI":"10.1186\/s12866-021-02433-6"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijantimicag.2017.09.012","article-title":"Gentamicin Synergises with Azoles against Drug-Resistant Candida albicans","volume":"51","author":"Lu","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3389\/fmicb.2018.03142","article-title":"Linezolid in Combination With Azoles Induced Synergistic Effects Against Candida albicans and Protected Galleria mellonella Against Experimental Candidiasis","volume":"9","author":"Lu","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13756-019-0521-7","article-title":"In Vitro Polymyxin Activity against Clinical Multidrug-Resistant Fungi","volume":"8","author":"Yousfi","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Schwarz, P., Djenontin, E., and Dannaoui, E. (2020). Colistin and Isavuconazole Interact Synergistically In Vitro against Aspergillus nidulans and Aspergillus niger. Microorganisms, 8.","DOI":"10.3390\/microorganisms8091447"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"21448","DOI":"10.1038\/s41598-020-78588-5","article-title":"In Vitro Synergy of Isavuconazole in Combination with Colistin against Candida auris","volume":"10","author":"Schwarz","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e02361-17","DOI":"10.1128\/AAC.02361-17","article-title":"Synergy between Pyrvinium Pamoate and Azoles against Exophiala dermatitidis","volume":"62","author":"Gao","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.04229-14","article-title":"Artemisinins, New Miconazole Potentiators Resulting in Increased Activity against Candida albicans Biofilms","volume":"59","author":"Lanckacker","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1128\/AAC.04417-14","article-title":"Synergistic Activity of Chloroquine with Fluconazole against Fluconazole-Resistant Isolates of Candida Species","volume":"59","author":"Li","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3389\/fmicb.2016.01658","article-title":"INK128 Exhibits Synergy with Azoles against Exophiala spp. and Fusarium spp.","volume":"7","author":"Gao","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e02331-19","DOI":"10.1128\/AAC.02331-19","article-title":"Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates","volume":"64","author":"Montoya","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bjid.2015.11.003","article-title":"Antiretroviral Drugs Saquinavir and Ritonavir Reduce Inhibitory Concentration Values of Itraconazole against Histoplasma capsulatum Strains In Vitro","volume":"20","author":"Brilhante","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1128\/AAC.00294-13","article-title":"Potentiation of Azole Antifungals by 2-Adamantanamine","volume":"57","author":"LaFleur","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"105804","DOI":"10.1016\/j.ijantimicag.2019.09.008","article-title":"Antifungal Activity of Ribavirin Used Alone or in Combination with Fluconazole against Candida albicans Is Mediated by Reduced Virulence","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e00684-20","DOI":"10.1128\/AAC.00684-20","article-title":"Potent Synergistic Interactions between Lopinavir and Azole Antifungal Drugs against Emerging Multidrug-Resistant Candida auris","volume":"65","author":"Eldesouky","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1007\/s11033-019-05020-1","article-title":"The Efflux Pump Inhibitor Tetrandrine Exhibits Synergism with Fluconazole or Voriconazole against Candida parapsilosis","volume":"46","author":"Zhao","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1089\/mdr.2016.0217","article-title":"Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus","volume":"23","author":"Li","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phymed.2018.06.003","article-title":"Tetrandrine Enhances the Antifungal Activity of Fluconazole in a Murine Model of Disseminated Candidiasis","volume":"46","author":"Shi","year":"2018","journal-title":"Phytomedicine"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1099\/jmm.0.000120","article-title":"An In Vitro and In Vivo Study on the Synergistic Effect and Mechanism of Itraconazole or Voriconazole Alone and in Combination with Tetrandrine against Aspergillus fumigatus","volume":"64","author":"Li","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3389\/fmicb.2019.01266","article-title":"In Vitro and In Vivo Efficacy of a Synergistic Combination of Itraconazole and Verapamil Against Aspergillus fumigatus","volume":"10","author":"Zeng","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AAC.48.4.1335-1343.2004","article-title":"Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole","volume":"48","author":"Afeltra","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fcimb.2019.00211","article-title":"Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant Candida albicans by Competitively Inhibiting Efflux Pump","volume":"9","author":"Xu","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_161","first-page":"199","article-title":"Cis-2-Dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-Resistant Candida albicans","volume":"32","author":"Yang","year":"2019","journal-title":"Biomed. Environ. Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1038\/s41467-020-20183-3","article-title":"An Oxindole Efflux Inhibitor Potentiates Azoles and Impairs Virulence in the Fungal Pathogen Candida auris","volume":"11","author":"Iyer","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1038\/s41598-020-62976-y","article-title":"Ospemifene Displays Broad-Spectrum Synergistic Interactions with Itraconazole through Potent Interference with Fungal Efflux Activities","volume":"10","author":"Eldesouky","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"33687","DOI":"10.1038\/srep33687","article-title":"Quinone Derivatives Isolated from the Endolichenic Fungus Phialocephala fortinii Are Mdr1 Modulators That Combat Azole Resistance in Candida albicans","volume":"6","author":"Xie","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Singh, S., Fatima, Z., Ahmad, K., and Hameed, S. (2018). Fungicidal Action of Geraniol against Candida albicans Is Potentiated by Abrogated CaCdr1p Drug Efflux and Fluconazole Synergism. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203079"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","article-title":"In Vitro Synergistic Interactions of the Effects of Various Statins and Azoles against Some Clinically Important Fungi","volume":"307","author":"Nyilasi","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_167","first-page":"140","article-title":"Susceptibility of Clinically Important Dermatophytes against Statins and Different Statin-Antifungal Combinations","volume":"52","author":"Nyilasi","year":"2013","journal-title":"Med. Mycol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1007\/s00253-018-8959-8","article-title":"Lovastatin Synergizes with Itraconazole against Planktonic Cells and Biofilms of Candida albicans through the Regulation on Ergosterol Biosynthesis Pathway","volume":"102","author":"Zhou","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijantimicag.2017.04.005","article-title":"Atorvastatin as a Promising Anticryptococcal Agent","volume":"49","author":"Costa","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bjid.2015.06.001","article-title":"Simvastatin Inhibits Planktonic Cells and Biofilms of Candida and Cryptococcus Species","volume":"19","author":"Brilhante","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1038\/s41598-020-64571-7","article-title":"Repurposing Approach Identifies Pitavastatin as a Potent Azole Chemosensitizing Agent Effective against Azole-Resistant Candida Species","volume":"10","author":"Eldesouky","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e01753-20","DOI":"10.1128\/AAC.01753-20","article-title":"The Antifungal and Synergistic Effect of Bisphosphonates in Cryptococcus","volume":"65","author":"Kane","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_173","first-page":"279","article-title":"Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis","volume":"185","author":"Aneke","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_174","first-page":"1012","article-title":"In Vitro Effects of Promethazine on Cell Morphology and Structure and Mitochondrial Activity of Azole-Resistant Candida tropicalis","volume":"56","author":"Brilhante","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/mmy\/myy088","article-title":"Synergistic Combinations of Azoles and Antihistamines against Candida Species In Vitro","volume":"57","author":"Dennis","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijantimicag.2017.03.015","article-title":"Strong Synergism of Dexamethasone in Combination with Fluconazole against Resistant Candida albicans Mediated by Inhibiting Drug Efflux and Reducing Virulence","volume":"50","author":"Sun","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Li, X., Yu, C., Huang, X., and Sun, S. (2016). Synergistic Effects and Mechanisms of Budesonide in Combination with Fluconazole against Resistant Candida albicans. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168936"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"116827","DOI":"10.1016\/j.lfs.2019.116827","article-title":"In Vitro Synergy of Azole Antifungals and Methotrexate against Candida albicans","volume":"235","author":"Yang","year":"2019","journal-title":"Life Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2017.07.030","article-title":"Repurposing Antipsychotic Drugs into Antifungal Agents: Synergistic Combinations of Azoles and Bromperidol Derivatives in the Treatment of Various Fungal Infections","volume":"139","author":"Holbrook","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/AAC.03046-15","article-title":"The Synergistic Effect of Azoles and Fluoxetine against Resistant Candida albicans Strains Is Attributed to Attenuating Fungal Virulence","volume":"60","author":"Gu","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Cong, L., Liao, Y., Yang, S., and Yang, R. (2016). In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167903"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Jia, W., Zhang, H., Li, C., Li, G., Liu, X., and Wei, J. (2016). The Calcineruin Inhibitor Cyclosporine a Synergistically Enhances the Susceptibility of Candida albicans Biofilms to Fluconazole by Multiple Mechanisms. BMC Microbiol., 16.","DOI":"10.1186\/s12866-016-0728-1"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"e4999","DOI":"10.7717\/peerj.4999","article-title":"Synergistic and Antagonistic Effects of Immunomodulatory Drugs on the Action of Antifungals against Candida glabrata and Saccharomyces cerevisiae","volume":"2018","author":"Tome","year":"2018","journal-title":"PeerJ"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/AAC.47.3.956-964.2003","article-title":"Ergosterol Biosynthesis Inhibitors Become Fungicidal When Combined with Calcineurin Inhibitors against Candida albicans, Candida glabrata, and Candida krusei","volume":"47","author":"Onyewu","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01397-07","article-title":"Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms","volume":"52","author":"Uppuluri","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1128\/AAC.48.5.1664-1669.2004","article-title":"In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus","volume":"48","author":"Steinbach","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans","volume":"44","author":"Marchetti","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"e00948-17","DOI":"10.1128\/AAC.00948-17","article-title":"Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis","volume":"61","author":"Gao","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1128\/AAC.01510-15","article-title":"In Vitro Interactions of Antifungal Agents and Tacrolimus against Aspergillus Biofilms","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/S1517-838246120120442","article-title":"Synergistic Effects of Tacrolimus and Azole Antifungal Compounds in Fluconazole-Susceptible and Fluconazole-Resistant Candida glabrata Isolates","volume":"46","author":"Denardi","year":"2015","journal-title":"Braz. J. Microbiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bjid.2016.08.008","article-title":"Antifungal Activities of Tacrolimus in Combination with Antifungal Agents against Fluconazole-Susceptible and Fluconazole-Resistant Trichosporon asahii Isolates","volume":"20","author":"Denardi","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3389\/fmicb.2017.01759","article-title":"Tacrolimus Increases the Effectiveness of Itraconazole and Fluconazole against Sporothrix spp.","volume":"8","author":"Ramos","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.mycmed.2018.09.003","article-title":"Tacrolimus, Not Triamcinolone Acetonide, Interacts Synergistically with Itraconazole, Terbinafine, Bifonazole, and Amorolfine against Clinical Dermatophyte Isolates","volume":"28","author":"Zhang","year":"2018","journal-title":"J. De Mycol. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41598-019-57174-4","article-title":"Proton Pump Inhibitors Act Synergistically with Fluconazole against Resistant Candida albicans","volume":"10","author":"Lu","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/10715762.2019.1610563","article-title":"Synergistic Effects of Geldanamycin with Fluconazole Are Associated with Reactive Oxygen Species in Candida tropicalis Resistant to Azoles and Amphotericin B","volume":"53","author":"Jia","year":"2019","journal-title":"Free Radic. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/1751-7915.13814","article-title":"Repurposing the FDA-Approved Anticancer Agent Ponatinib as a Fluconazole Potentiator by Suppression of Multidrug Efflux and Pma1 Expression in a Broad Spectrum of Yeast Species","volume":"15","author":"Liu","year":"2022","journal-title":"Microb. Biotechnol."},{"key":"ref_197","first-page":"2589","article-title":"The Non-Geldanamycin Hsp90 Inhibitors Enhanced the Antifungal Activity of Fluconazole","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"myw131","DOI":"10.1093\/mmy\/myw131","article-title":"Givinostat Exhibits In Vitro Synergy with Posaconazole against Aspergillus spp.","volume":"55","author":"Sun","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/mmy\/myx072","article-title":"Lonafarnib Synergizes with Azoles against Aspergillus spp. and Exophiala spp.","volume":"56","author":"Qiao","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/iub.1973","article-title":"Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans","volume":"71","author":"Kim","year":"2019","journal-title":"IUBMB Life"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijantimicag.2016.06.012","article-title":"Synergy and Antagonism between Iron Chelators and Antifungal Drugs in Cryptococcus","volume":"48","author":"Lai","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.3389\/fmicb.2019.02853","article-title":"The Synergistic Antifungal Effect and Potential Mechanism of D-Penicillamine Combined With Fluconazole Against Candida albicans","volume":"10","author":"Li","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3389\/fmicb.2017.02101","article-title":"Synergistic Antifungal Effect of Fluconazole Combined with Licofelone against Resistant Candida albicans","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1139\/cjm-2018-0337","article-title":"The Synergistic Antifungal Effects of Sodium Phenylbutyrate Combined with Azoles against Candida albicans via the Regulation of the Ras\u2013CAMP\u2013PKA Signalling Pathway and Virulence","volume":"65","author":"Sun","year":"2019","journal-title":"Can. J. Microbiol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/myc.12824","article-title":"In Vitro Interactions between 17-AAG and Azoles against Exophiala dermatitidis","volume":"61","author":"Gao","year":"2018","journal-title":"Mycoses"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/fmb-2019-0082","article-title":"Synergistic Effects of Ketamine and Azole Derivatives on Candida Spp. Resistance to Fluconazole","volume":"15","author":"Barroso","year":"2020","journal-title":"Future Microbiol."},{"key":"ref_207","first-page":"26","article-title":"Indifferent Effect of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Combined with Fluconazole against Multidrug-Resistant Candida auris","volume":"5","author":"Ahangarkani","year":"2019","journal-title":"Curr. Med. Mycol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jiac.2021.09.018","article-title":"Activity of Chlorhexidine Acetate in Combination with Fluconazole against Suspensions and Biofilms of Candida auris","volume":"28","author":"Hao","year":"2022","journal-title":"J. Infect. Chemother."},{"key":"ref_209","first-page":"1280","article-title":"Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans","volume":"12","author":"Yuan","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fmicb.2021.673035","article-title":"The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na+\/H+ Exchangers","volume":"12","author":"Vu","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2012.09.016","article-title":"Reversal of Efflux Mediated Antifungal Resistance Underlies Synergistic Activity of Two Monoterpenes with Fluconazole","volume":"48","author":"Ahmad","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41598-020-58203-3","article-title":"Improved Efficacy of Antifungal Drugs in Combination with Monoterpene Phenols against Candida auris","volume":"10","author":"Shaban","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5897\/JMPR2016.6048","article-title":"Antifungal Activity and Synergistic Effect of Acetophenones Isolated from Species Croton against Dermatophytes and Yeasts","volume":"10","author":"Albuquerque","year":"2016","journal-title":"J. Med. Plants Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"e00436-17","DOI":"10.1128\/AAC.00436-17","article-title":"Potent In Vitro Synergism of Fluconazole and Osthole against Fluconazole-Resistant Candida albicans","volume":"61","author":"Li","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/13880209.2016.1237977","article-title":"Synergistic In Vitro Activity of Sodium Houttuyfonate with Fluconazole against Clinical Candida albicans Strains under Planktonic Growing Conditions","volume":"55","author":"Shao","year":"2017","journal-title":"Pharm. Biol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.micpath.2017.04.021","article-title":"Synergistic Anticandidal Activity of Menthol in Combination with Itraconazole and Nystatin against Clinical Candida glabrata and Candida krusei Isolates","volume":"107","author":"Sharifzadeh","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_217","first-page":"12","article-title":"Exogenous Tyrosol Inhibits Planktonic Cells and Biofilms of Candida Species and Enhances Their Susceptibility to Antifungals","volume":"15","author":"Teixeira","year":"2015","journal-title":"FEMS Yeast Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4014\/jmb.1607.07072","article-title":"Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against Candida albicans Biofilms","volume":"27","author":"Raut","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3389\/fmicb.2019.01461","article-title":"Antifungal Activity and Potential Mechanism of N-Butylphthalide Alone and in Combination with Fluconazole against Candida albicans","volume":"10","author":"Gong","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.riam.2020.12.005","article-title":"In Vitro Interaction between Glabridin and Voriconazole against Aspergillus fumigatus Isolates","volume":"38","author":"Nabili","year":"2021","journal-title":"Rev. Iberoam. De Micol."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Ganan, M., Lorentzen, S.B., Gaustad, P., and S\u00f8rlie, M. (2021). Synergistic Antifungal Activity of Chito-Oligosaccharides and Commercial Antifungals on Biofilms of Clinical Candida Isolates. J. Fungi, 7.","DOI":"10.3390\/jof7090718"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jgar.2020.10.025","article-title":"Reversal of Azole Resistance in Candida albicans by Oridonin","volume":"24","author":"Chen","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.micpath.2017.04.020","article-title":"Novel Properties of Hippophae Rhamnoides L. Twig and Leaf Extracts\u2014Anti-Virulence Action and Synergy with Antifungals Studied In Vitro on Candida Spp. Model","volume":"107","author":"Sadowska","year":"2017","journal-title":"Microb. Pathog."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3109\/13880209.2016.1158286","article-title":"Reversal of Fluconazole Resistance Induced by a Synergistic Effect with Acca sellowiana in Candida glabrata Strains","volume":"54","author":"Pippi","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/lam.12683","article-title":"Synergistic Antimicrobial Activity of Boswellia serrata Roxb. Ex Colebr. (Burseraceae) Essential Oil with Various Azoles against Pathogens Associated with Skin, Scalp and Nail Infections","volume":"63","author":"Sadhasivam","year":"2016","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Roana, J., Mandras, N., Scalas, D., Campagna, P., and Tullio, V. (2021). Antifungal Activity of Melaleuca alternifolia Essential Oil (TTO) and Its Synergy with Itraconazole or Ketoconazole against Trichophyton rubrum. Molecules, 26.","DOI":"10.3390\/molecules26020461"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jgar.2017.12.011","article-title":"Fluconazole Inhibits Cellular Ergosterol Synthesis to Confer Synergism with Berberine against Yeast Cells","volume":"13","author":"Yang","year":"2018","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1128\/AAC.00499-13","article-title":"Fluconazole Assists Berberine to Kill Fluconazole-Resistant Candida albicans","volume":"57","author":"Li","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.archoralbio.2010.11.021","article-title":"In Vitro Synergism between Berberine and Miconazole against Planktonic and Biofilm Candida Cultures","volume":"56","author":"Wei","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"ref_230","first-page":"201","article-title":"In Vitro Antifungal Activity of the Berberine and Its Synergism with Fluconazole","volume":"97","author":"Iwazaki","year":"2010","journal-title":"Int. J. Gen. Mol. Microbiol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/AAC.50.3.1096-1099.2006","article-title":"Potent In Vitro Synergism of Fluconazole and Berberine Chloride against Clinical Isolates of Candida albicans Resistant to Fluconazole","volume":"50","author":"Quan","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11046-019-00325-y","article-title":"In Vitro Susceptibility of Berberine Combined with Antifungal Agents Against the Yeast Form of Talaromyces marneffei","volume":"184","author":"Luo","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3389\/fmicb.2018.02892","article-title":"Strong Synergism of Palmatine and Fluconazole\/Itraconazole Against Planktonic and Biofilm Cells of Candida Species and Efflux-Associated Antifungal Mechanism","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.20546\/ijcmas.2018.702.435","article-title":"Antifungal Activity of Palmatine against Strains of Candida Spp. Resistant to Azoles in Planktonic Cells and Biofilm","volume":"7","author":"Campos","year":"2018","journal-title":"Int. J. Curr. Microbiol. Appl. Sci."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3389\/fmicb.2019.02295","article-title":"Synergistic Effects and Mechanisms of Combined Treatment With Harmine Hydrochloride and Azoles for Resistant Candida albicans","volume":"10","author":"Li","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.mycmed.2018.07.006","article-title":"Promising Synergistic Activity of Fluconazole with Bioactive Guttiferone-A and Derivatives against Non-albicans Candida Species","volume":"28","author":"Cusinato","year":"2018","journal-title":"J. De Mycol. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3389\/fmicb.2020.00957","article-title":"In Vitro and In Vivo Effect of Exogenous Farnesol Exposure Against Candida auris","volume":"11","author":"Nagy","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"111568","DOI":"10.1016\/j.biopha.2021.111568","article-title":"Antifungal Activity and Potential Mechanism of Asiatic Acid Alone and in Combination with Fluconazole against Candida albicans","volume":"139","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jam.12737","article-title":"Synergistic Activity of Magnolol with Azoles and Its Possible Antifungal Mechanism against Candida albicans","volume":"118","author":"Sun","year":"2015","journal-title":"J. Appl. Microbiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsyr\/fov001","article-title":"Synergistic and Drug-Resistant Reversing Effects of Diorcinol D Combined with Fluconazole against Candida albicans","volume":"15","author":"Li","year":"2015","journal-title":"FEMS Yeast Res."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/13880209.2016.1242631","article-title":"In Vitro Synergism of a Water Insoluble Fraction of Uncaria tomentosa Combined with Fluconazole and Terbinafine against Resistant Non-Candida albicans Isolates","volume":"55","author":"Moraes","year":"2017","journal-title":"Pharm. Biol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mycmed.2019.01.011","article-title":"Synergistic Effects of Tea Polyphenol Epigallocatechin 3-O-Gallate and Azole Drugs against Oral Candida Isolates","volume":"29","author":"Behbehani","year":"2019","journal-title":"J. De Mycol. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1007\/s12010-015-1537-y","article-title":"Asarones from Acorus calamus in Combination with Azoles and Amphotericin B: A Novel Synergistic Combination to Compete Against Human Pathogenic Candida Species In Vitro","volume":"175","author":"Kumar","year":"2015","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"e0010021","DOI":"10.1128\/AAC.00100-21","article-title":"Pyrogallol and Fluconazole Interact Synergistically In Vitro against Candida glabrata through an Efflux-Associated Mechanism","volume":"65","author":"Yao","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7883\/yoken.64.292","article-title":"Synergistic Antifungal Effect of Lactoferrin with Azole Antifungals against Candida albicans and a Proposal for a New Treatment Method for Invasive Candidiasis","volume":"64","author":"Kobayashi","year":"2011","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1128\/AAC.01959-16","article-title":"Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29","volume":"60","author":"Tebung","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"e01106-16","DOI":"10.1128\/AAC.01106-16","article-title":"In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and-Resistant Isolates of Candida Species","volume":"61","author":"Fakhim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11046-015-9899-9","article-title":"Anti-Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole","volume":"180","author":"Shi","year":"2015","journal-title":"Mycopathologia"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acsmedchemlett.6b00355","article-title":"Potent Antifungal Synergy of Phthalazinone and Isoquinolones with Azoles Against Candida albicans","volume":"8","author":"Mood","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Li, L.P., Liu, W., Liu, H., Zhu, F., Zhang, D.Z., Shen, H., Xu, Z., Qi, Y.P., Zhang, S.Q., and Chen, S.M. (2015). Synergistic Antifungal Activity of Berberine Derivative B-7b and Fluconazole. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126393"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1128\/AAC.01061-16","article-title":"The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis","volume":"60","author":"Koselny","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"e00244-18","DOI":"10.1128\/AAC.00244-18","article-title":"Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis","volume":"62","author":"Ghannoum","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"e02576-17","DOI":"10.1128\/AAC.02576-17","article-title":"Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator Dibi Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis","volume":"62","author":"Savage","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bmcl.2014.11.022","article-title":"Design, Synthesis, and Evaluation of Caffeic Acid Amides as Synergists to Sensitize Fluconazole-Resistant Candida albicans to Fluconazole","volume":"25","author":"Dai","year":"2015","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.bmcl.2016.05.013","article-title":"The Synthesis and Synergistic Antifungal Effects of Chalcones against Drug Resistant Candida albicans","volume":"26","author":"Wang","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_256","first-page":"1045","article-title":"In Vitro Interactions between IAP Antagonist AT406 and Azoles against Planktonic Cells and Biofilms of Pathogenic Fungi Candida albicans and Exophiala dermatitidis","volume":"56","author":"Sun","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1021\/acsinfecdis.0c00849","article-title":"Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis","volume":"7","author":"Yang","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"113961","DOI":"10.1016\/j.ejmech.2021.113961","article-title":"Heat Shock Protein 90 (Hsp90)\/Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Azoles-Resistant Candida albicans","volume":"227","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Czechowicz, P., Neubauer, D., Nowicka, J., Kamysz, W., and Go\u015bciniak, G. (2021). Antifungal Activity of Linear and Disulfide-Cyclized Ultrashort Cationic Lipopeptides Alone and in Combination with Fluconazole against Vulvovaginal Candida spp.. Pharmaceutics, 13.","DOI":"10.21203\/rs.3.rs-440442\/v1"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"e0200721","DOI":"10.1128\/spectrum.02007-21","article-title":"In Vitro and In Vivo Interactions of TOR Inhibitor AZD8055 and Azoles against Pathogenic Fungi","volume":"10","author":"Sun","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/21505594.2016.1257457","article-title":"New Facets of Antifungal Therapy","volume":"8","author":"Chang","year":"2017","journal-title":"Virulence"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/AAC.01506-08","article-title":"In Vitro Activity of Terbinafine Combined with Caspofungin and Azoles against Pythium insidiosum","volume":"53","author":"Cavalheiro","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.01075-07","article-title":"In Vitro Activities of Voriconazole, Itraconazole, and Terbinafine Alone or in Combination against Pythium insidiosum Isolates from Brazil","volume":"52","author":"Argenta","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"e00238-18","DOI":"10.1128\/AAC.00238-18","article-title":"Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris","volume":"62","author":"Kordalewska","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to Azoles and Echinocandins Worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3389\/fmicb.2014.00671","article-title":"Antifungal Amphiphilic Aminoglycoside K20: Bioactivities and Mechanism of Action","volume":"5","author":"Shrestha","year":"2014","journal-title":"Front. Microbiol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1046\/j.1432-1327.2001.02116.x","article-title":"A Subfraction of the Yeast Endoplasmic Reticulum Associates with the Plasma Membrane and Has a High Capacity to Synthesize Lipids","volume":"268","author":"Pichler","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"ref_269","first-page":"1160","article-title":"Structural Mechanism for Statin Inhibition of HMG-CoA Reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science (1979)"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing Bisphosphonates","volume":"264","author":"Pieterman","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/00003495-199243020-00010","article-title":"Terbinafine: A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Superficial Mycoses","volume":"43","author":"Balfour","year":"1992","journal-title":"Drugs"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000247588","article-title":"Preclinical Data and Mode of Action of Amorolfine","volume":"184","author":"Polak","year":"1992","journal-title":"Dermatology"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2169\/internalmedicine.56.8313","article-title":"Acute Kidney Injury from Excessive Potentiation of Calcium-Channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole","volume":"56","author":"Mishima","year":"2017","journal-title":"Intern. Med."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.42.7.1695","article-title":"Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, in Candida glabrata","volume":"42","author":"Miyazaki","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1128\/AAC.40.12.2835","article-title":"Multiple Efflux Mechanisms Are Involved in Candida albicans Fluconazole Resistance","volume":"40","author":"Albertson","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jac\/dkt075","article-title":"The Cdr1B Efflux Transporter Is Associated with Non-Cyp51a-Mediated Itraconazole Resistance in Aspergillus Fumigatus","volume":"68","author":"Fraczek","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11046-008-9110-7","article-title":"Antifungal Resistance Mechanisms in Dermatophytes","volume":"166","author":"Peres","year":"2008","journal-title":"Mycopathologia"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/dkg050","article-title":"The Importance of Efflux Pumps in Bacterial Antibiotic Resistance","volume":"51","author":"Webber","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"9862","DOI":"10.1021\/bi050061f","article-title":"Evidence for a Pfcrt-Associated Chloroquine Efflux System in the Human Malarial Parasite Plasmodium falciparum","volume":"44","author":"Sanchez","year":"2005","journal-title":"Biochemistry"},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Liu, S., Yue, L., Gu, W., Li, X., Zhang, L., and Sun, S. (2016). Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0150859"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1038\/s41467-018-07633-9","article-title":"Efflux Pump-Mediated Resistance to Antifungal Compounds Can Be Prevented by Conjugation with Triphenylphosphonium Cation","volume":"9","author":"Chang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"112218","DOI":"10.1016\/j.biopha.2021.112218","article-title":"In Vitro Activities of Carvacrol, Cinnamaldehyde and Thymol against Candida Biofilms","volume":"143","author":"Mateo","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fphar.2014.00202","article-title":"Efflux Pump Proteins in Antifungal Resistance","volume":"5","author":"Prasad","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The Antifungal Pipeline: A Reality Check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug Repurposing: Progress, Challenges and Recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.riam.2012.09.006","article-title":"Synergistic Antifungal Activity of Statin-Azole Associations as Witnessed by Saccharomyces cerevisiae- and Candida utilis-Bioassays and Ergosterol Quantification","volume":"30","author":"Cabral","year":"2013","journal-title":"Rev. Iberoam. De Micol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-Associated Side Effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1345\/aph.1C467","article-title":"Simvastatin\u2013Fluconazole Causing Rhabdomyolysis","volume":"37","author":"Shaukat","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: Mechanism of Action and Role in Clinical Practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the Jaws Associated with the Use of Bisphosphonates: A Review of 63 Cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00262-010-0887-0","article-title":"Aminobisphosphonate-Pretreated Dendritic Cells Trigger Successful V\u03b39V\u03b42 T Cell Amplification for Immunotherapy in Advanced Cancer Patients","volume":"59","author":"Cabillic","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/313943","article-title":"Antifungal Prophylaxis for Solid Organ Transplant Recipients: Seeking Clarity amidst Controversy","volume":"31","author":"Singh","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/EC.00138-13","article-title":"The Calcineurin Pathway Inhibitor Tacrolimus Enhances the In Vitro Activity of Azoles against Mucorales via Apoptosis","volume":"12","author":"Shirazi","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0006-291X(03)01552-3","article-title":"Calcineurin Signaling in Saccharomyces cerevisiae: How Yeast Go Crazy in Response to Stress","volume":"311","author":"Cyert","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2174\/138161211795703726","article-title":"Microbial Efflux Pump Inhibition: Tactics and Strategies","volume":"17","author":"Tegos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1101\/gad.13.7.798","article-title":"Yeast Calcineurin Regulates Nuclear Localization of the Crz1p Transcription Factor through Dephosphorylation","volume":"13","author":"Guo","year":"1999","journal-title":"Genes Dev."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The Re-Emergence of Natural Products for Drug Discovery in the Genomics Era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1021\/pr9005074","article-title":"Proteomic Analysis Reveals a Synergistic Mechanism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans: Endogenous ROS Augmentation","volume":"8","author":"Xu","year":"2009","journal-title":"J. Proteome Res."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2174\/138527212799957995","article-title":"Antioxidant Activity of Plant Phenols: Chemical Mechanisms and Biological Significance","volume":"16","author":"Dangles","year":"2012","journal-title":"Curr. Org. Chem."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3389\/fmicb.2019.00829","article-title":"Antibacterial Properties of Polyphenols: Characterization and QSAR (Quantitative Structure-Activity Relationship) Models","volume":"10","author":"Forquet","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"21049","DOI":"10.1038\/s41598-021-00485-2","article-title":"Catechol Thwarts Virulent Dimorphism in Candida albicans and Potentiates the Antifungal Efficacy of Azoles and Polyenes","volume":"11","author":"Jothi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/ph6121543","article-title":"Antimicrobial Peptides","volume":"6","author":"Bahar","year":"2013","journal-title":"Pharmaceuticals"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"104771","DOI":"10.1016\/j.bioorg.2021.104771","article-title":"Azole-Triphenylphosphonium Conjugates Combat Antifungal Resistance and Alleviate the Development of Drug-Resistance","volume":"110","author":"Wang","year":"2021","journal-title":"Bioorganic Chem."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"113524","DOI":"10.1016\/j.ejmech.2021.113524","article-title":"Lanosterol 14\u03b1-Demethylase (CYP51)\/Histone Deacetylase (HDAC) Dual Inhibitors for Treatment of Candida tropicalis and Cryptococcus neoformans Infections","volume":"221","author":"Zhu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/acs.jmedchem.1c01807","article-title":"Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles","volume":"65","author":"Elias","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"10170","DOI":"10.1073\/pnas.96.18.10170","article-title":"Role for Yeast Inhibitor of Apoptosis (IAP)-like Proteins in Cell Division","volume":"96","author":"Uren","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmicb.2017.00036","article-title":"Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis","volume":"8","author":"Scorzoni","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/acs.cgd.8b01873","article-title":"Cocrystal Engineering of Itraconazole with Suberic Acid via Rotary Evaporation and Spray Drying","volume":"19","author":"Weng","year":"2019","journal-title":"Cryst. Growth Des."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/4\/482\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:54:30Z","timestamp":1760136870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/4\/482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":308,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ph15040482"],"URL":"https:\/\/doi.org\/10.3390\/ph15040482","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202203.0262.v1","asserted-by":"object"}]},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]}}}